These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 26164457)
1. MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma. Wang K; Xie D; Xie J; Wan Y; Ma L; Qi X; Yang S Neuroreport; 2015 Aug; 26(12):695-702. PubMed ID: 26164457 [TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway. Kong LY; Xue M; Zhang QC; Su CF Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945 [TBL] [Abstract][Full Text] [Related]
3. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway. Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway. Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1. Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling. Shi M; Tian P; Liu Z; Zhang F; Zhang Y; Qu L; Liu X; Wang Y; Zhou X; Xiao Y; Guo B Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484208 [TBL] [Abstract][Full Text] [Related]
7. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting Wu F; Li J; Guo N; Wang XH; Liao YQ Am J Cancer Res; 2017; 7(3):405-416. PubMed ID: 28401000 [TBL] [Abstract][Full Text] [Related]
8. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699 [TBL] [Abstract][Full Text] [Related]
10. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC. Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746 [TBL] [Abstract][Full Text] [Related]
11. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma. Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164 [TBL] [Abstract][Full Text] [Related]
12. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Gu W; Li X; Wang J Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507 [TBL] [Abstract][Full Text] [Related]
13. miR-191 Inhibition Induces Apoptosis Through Reactivating Secreted Frizzled-Related Protein-1 in Cholangiocarcinoma. Kang PC; Leng KM; Liu YP; Liu Y; Xu Y; Qin W; Gao JJ; Wang ZD; Tai S; Zhong XY; Cui YF Cell Physiol Biochem; 2018; 49(5):1933-1942. PubMed ID: 30235453 [TBL] [Abstract][Full Text] [Related]
14. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296 [TBL] [Abstract][Full Text] [Related]
15. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling. Chen L; Zhang A; Li Y; Zhang K; Han L; Du W; Yan W; Li R; Wang Y; Wang K; Pu P; Jiang T; Jiang C; Kang C Cancer Lett; 2013 Feb; 329(2):174-80. PubMed ID: 23142218 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells. Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502 [TBL] [Abstract][Full Text] [Related]
17. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway. Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492 [TBL] [Abstract][Full Text] [Related]
18. MiR-27a targets sFRP1 in hFOB cells to regulate proliferation, apoptosis and differentiation. Guo D; Li Q; Lv Q; Wei Q; Cao S; Gu J PLoS One; 2014; 9(3):e91354. PubMed ID: 24625818 [TBL] [Abstract][Full Text] [Related]
19. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway. Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]